Wayne State scientists are developing artificial intelligence models to cut costs in complex drug design, while Stanford research reveals ChatGPT-4 achieving 92% medical diagnostic accuracy — outperforming human doctors scoring 74%. This wave of AI breakthroughs is reflected in financial markets, where health tech stocks...
Artificial intelligence (AI) is transforming pharmaceutical research, compressing timelines and potentially slashing drug prices in an industry defined by decade-long development cycles and billion-dollar price tags. Get the Full Story Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS...
